10X Genomics, Inc.
(NASDAQ : TXG)

( )
TXG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.21%161.910.0%$1387.78m
NVAXNovavax, Inc. -2.57%221.5080.0%$650.79m
AMGNAmgen, Inc. 0.10%255.971.3%$554.37m
SNSSSunesis Pharmaceuticals, Inc. -5.63%7.550.7%$527.77m
ILMNIllumina, Inc. 1.30%404.183.5%$527.33m
REGNRegeneron Pharmaceuticals, Inc. -0.58%499.692.7%$447.00m
GILDGilead Sciences, Inc. -1.38%65.951.0%$437.06m
VRTXVertex Pharmaceuticals, Inc. -0.10%219.181.9%$383.57m
ALXNAlexion Pharmaceuticals, Inc. 1.09%165.472.0%$360.29m
BNTXBioNTech SE -1.36%149.480.0%$336.51m
BIIBBiogen, Inc. -0.47%269.051.7%$246.78m
NBIXNeurocrine Biosciences, Inc. -1.79%94.854.9%$180.78m
EXASEXACT Sciences Corp. -1.93%127.5318.4%$168.47m
CRSPCRISPR Therapeutics AG -2.97%115.040.6%$158.56m
SGENSeagen Inc. -1.02%144.015.8%$140.14m

Company Profile

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.